The risk of Clostridium difficile infection (CDI) in hospitalized patients may be halved by a strategy of administering probiotics within 2 days of antibiotic initiation, according to the results of a systematic review.
Warfarin, commonly used to treat thrombosis, should conventionally be administered to HIV-infected patients, according to a study showing that warfarin dosing is not significantly affected by HIV infection.
The non-nucleoside reverse transcriptase inhibitor antiretroviral therapy for HIV/AIDS may yield significantly higher rates of drug resistance compared with protease inhibitors and nucleoside reverse transcriptase inhibitors, a new study shows.
In immunocompromised patients with systemic rheumatic diseases, daily half-strength sulfamethoxazole-trimethoprim (SMX/TMP) appears to be an optimal regimen for chemoprophylaxis of Pneumocystis pneumonia (PJP), according to a study.
Many patients with HIV receiving ongoing treatment frequently engage in recreational drug use, a new cross-sectional study reports. Unfortunately, these substances may interfere with clinical outcomes and may potentially interact with the antiretroviral agents.
Among critically ill patients, platelet transfusion appears to be associated with hospital-acquired infection, according to a study.
Use of proton pump inhibitors (PPIs) to prevent bleeding in intensive care unit (ICU) patients does not contribute to an added risk of bloodstream infections, a study suggests.
Patients with amyotrophic lateral sclerosis (ALS) may be at high risk of sepsis compared with patients without the disease, a retrospective study suggests. Furthermore, the risk increases with the use of life support measures and decreases with exposure to β2-adrenoceptor agonists.
The novel bismuth-containing quadruple therapy with metronidazole and amoxicillin appears to be an attractive alternative to classical therapy with tetracycline for Helicobacter pylori rescue treatment, according to a study. The former demonstrates comparable eradication rates with superior safety and compliance.
Chronic hepatitis B (CHB) patients receiving oral medication may demonstrate better compliance with hepatocellular carcinoma (HCC) surveillance compared with similar patients not receiving any medications, a recent study suggests.